MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification, announced the public availability of preliminary data abstracts from two separate endocarditis stud
Full Story >>
Vote
+15